Cassava Sciences, a US biotech developing a novel, investigational treatment for Alzheimer’s disease (AD) dementia, was ...

Positive top-line results from the Phase III ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with pulmonary ...

The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for belantamab ...

New research presented at the RSNA meeting suggests that levothyroxine, a common treatment for hypothyroidism, may contribute ...

Specialist preclinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has ...

A patient in Neurogene’s ongoing Phase I/II trial for Rett syndrome—who was dosed on November 5 with 3E15 vg of NGN-401—has ...

Danish biotech Adcendo today announced the successful closing of an oversubscribed $135 million Series B financing round. The ...

Centauri Therapeutics secured a £1 million ($1.25 million) grant from PACE to advance its Alphamer technology, targeting ...

StemCyte, a subsidiary of StemCyte International, has secured approval from the US Food and Drug Administration for ...

The US Food and Drug Administration (FDA) has approved Imkeldi (imatinib) oral solution, the first oral liquid form of ...

In what could be construed to be India's quest for pharmaceutical supremacy, a clarion call has been made for the country to ...

UK pharma major AstraZeneca today released positive high-level results from the CAPItello-281 Phase III trial showing that ...